Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Relmada Therapeutics Inc (NQ: RLMD )

34.49 -0.20 (-0.58%)
Streaming Delayed Price Updated: 12:41 PM EDT, Apr 19, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 44,752
Open 34.50
Bid (Size) 34.21 (1)
Ask (Size) 34.59 (1)
Prev. Close 34.69
Today's Range 33.05 - 34.98
52wk Range 28.40 - 54.00
Shares Outstanding 16,745,930
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Relmada Therapeutics Announces Initiation of Second Pivotal Phase 3 Study of REL-1017 as Adjunctive Treatment for Patients with Major Depressive Disorder
Long-Term Safety Study Also Underway 
From PR Newswire
Relmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2020 Financial Results
Phase 3 Program for REL-1017 as Adjunctive Treatment for Major Depressive Disorder Initiated 
From PR Newswire

Performance

YTD
+4.58%
+4.58%
1 Month
-5.69%
-5.69%
3 Month
-9.14%
-9.14%
6 Month
+0.20%
+0.20%
1 Year
-2.57%
-2.57%

More News

Read More
Relmada Therapeutics to Report Fourth Quarter and Full-Year 2020 Financial Results and Host Conference Call and Webcast on March 23, 2021
From PR Newswire
Relmada Therapeutics Announces Participation in the Oppenheimer 31st Annual Healthcare Conference
From PR Newswire
Relmada Therapeutics Announces Participation in the 2021 SVB Leerink Global Healthcare Conference
From PR Newswire
Relmada Therapeutics Announces Initiation of Phase 3 Program for REL-1017 as Adjunctive Treatment for Patients with Major Depressive Disorder
From PR Newswire
Relmada Therapeutics to Participate in Upcoming Investor Conferences
From PR Newswire
On the Trail of Better Therapeutics for Depression
From PR Newswire
IHE's Underlying Holdings Could Mean 20% Gain Potential
Tags ETFs
From ETF Channel
Implied XPH Analyst Target Price: $68
Tags ETFs
From ETF Channel
On the Trail of Better Therapeutics for Depression
From InvestorBrandNetwork
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.